Thursday, July 9, 2026

pharma · Cancer · PBLS

Parabilis Medicines

Parabilis Medicines clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Villejust, FR HQ
2004 Founded
8 Employees
Public company Type
PBLS · NYSE Ticker
Company details
Status
Public
HQ
Villejust, FR
Founded
2004
Employees
8
Programs
1
Drugs
0
Patents
1
Intelligence · Clinical Programs

Parabilis Medicines projects

1 ClinicalTrials.gov programs sponsored by Parabilis Medicines.

Parabilis Medicines has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. FOG-001

    Parabilis Medicines

    Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Parabilis Medicines have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.